Ratings by Oppenheimer (Mark Breindenbach)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
9/29/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
8/17/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
5/12/2022 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
5/4/2021 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
2/23/2021 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details | ||
3/13/2020 | BioLineRx | BLRX | Maintain | Outperform (N/A) |
|
Details |